AU2009239385A1 - Methods of treating fungal infections - Google Patents

Methods of treating fungal infections Download PDF

Info

Publication number
AU2009239385A1
AU2009239385A1 AU2009239385A AU2009239385A AU2009239385A1 AU 2009239385 A1 AU2009239385 A1 AU 2009239385A1 AU 2009239385 A AU2009239385 A AU 2009239385A AU 2009239385 A AU2009239385 A AU 2009239385A AU 2009239385 A1 AU2009239385 A1 AU 2009239385A1
Authority
AU
Australia
Prior art keywords
alkyl
optionally substituted
aryl
halogen
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2009239385A
Other languages
English (en)
Inventor
Michael David Lafleur
Kim Lewis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northeastern University
Original Assignee
Northeastern University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northeastern University filed Critical Northeastern University
Publication of AU2009239385A1 publication Critical patent/AU2009239385A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2009239385A 2008-04-22 2009-04-22 Methods of treating fungal infections Abandoned AU2009239385A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4695308P 2008-04-22 2008-04-22
US61/046,953 2008-04-22
PCT/US2009/041403 WO2009132101A1 (en) 2008-04-22 2009-04-22 Methods of treating fungal infections

Publications (1)

Publication Number Publication Date
AU2009239385A1 true AU2009239385A1 (en) 2009-10-29

Family

ID=40790885

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2009239385A Abandoned AU2009239385A1 (en) 2008-04-22 2009-04-22 Methods of treating fungal infections

Country Status (8)

Country Link
US (1) US20120252820A1 (enExample)
EP (1) EP2282730A1 (enExample)
JP (1) JP2011518228A (enExample)
CN (1) CN102083425A (enExample)
AU (1) AU2009239385A1 (enExample)
CA (1) CA2722404A1 (enExample)
MX (1) MX2010011678A (enExample)
WO (1) WO2009132101A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150366890A1 (en) * 2013-02-25 2015-12-24 Trustees Of Boston University Compositions and methods for treating fungal infections
CN103800437A (zh) * 2013-12-31 2014-05-21 芜湖乐锐思信息咨询有限公司 一种治疗虫霉病的中药
CN105641678A (zh) * 2014-12-03 2016-06-08 博瑞生物医药（苏州）股份有限公司 阿尼芬净胃肠外制剂及制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6505398A (enExample) * 1965-04-28 1966-10-31
IL53440A0 (en) * 1977-11-22 1978-01-31 Teva Pharma 2-adamantyl hydrazines their preparation and pharmaceutical compositions containing them
US4923852A (en) * 1987-06-11 1990-05-08 Merck & Co., Inc. Aminoalkyl naphthalenediols as host resistance enhancers against viral infections
FR2631028B1 (fr) * 1988-05-09 1990-07-13 Cird Adamantyl-2 isothiazoline-4 ones-3, leur procede de preparation et leur utilisation comme agents bactericides et fongicides
WO2004024151A1 (en) * 2002-09-13 2004-03-25 New Pharma Research Sweden Ab Composition and potentiating method

Also Published As

Publication number Publication date
WO2009132101A1 (en) 2009-10-29
CA2722404A1 (en) 2009-10-29
CN102083425A (zh) 2011-06-01
EP2282730A1 (en) 2011-02-16
MX2010011678A (es) 2011-01-21
US20120252820A1 (en) 2012-10-04
JP2011518228A (ja) 2011-06-23

Similar Documents

Publication Publication Date Title
AU2008248118A1 (en) Methods of treating fungal infections
US9480679B2 (en) Methods for treating malaria, tuberculosis and MAC diseases
US8895561B2 (en) Compounds and methods for treating candidiasis and aspergillus infections
US20210077487A1 (en) Pharmaceutical composition containing hdac6 inhibitor as active ingredient for prevention or treatment of itching
WO2013166282A2 (en) Methods and compositions for treating bacterial infection
US20120252820A1 (en) Methods of treating fungal infections
CA2822806C (en) New amphotericin analogous compounds and pharmaceutical compositions containing them
US20040157837A1 (en) Combinations for the treatment of fungal infections
WO2011035225A1 (en) Synergistic combination therapy
US11655225B2 (en) Antimycobacterial heterocyclic amides
CN113332277B (zh) 一种吡咯二酮化合物在制备抗真菌药物中的应用
Simon et al. Preventing Candida albicans biofilm formation using aromatic-rich piperazines
CN114181225B (zh) 一种含笑内酯衍生物及其药物组合物、制备方法和用途
US20120095093A1 (en) Antifungal compounds
AU2011316657B8 (en) Methods of treating giardiasis
WO2022197740A1 (en) Biaryl amide and heteroaryl amides for treatment of candida albicans infection
AU2011316657B2 (en) Methods of treating giardiasis
EA048874B1 (ru) Противогрибковые агенты для деколонизации candida auris
Gowri et al. ÔØ Å ÒÙ× Ö ÔØ

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted